Crinetics Pharmaceuticals, Inc. - COM (CRNX)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / COM
Number of holders
232
Total Shares
84.5M
Shares change
+397K
Total reported value, excl. options
$4.32B
Value change
+$33.8M
Put/Call ratio
1.9
Number of buys
120
Number of sells
-100
Price
$51.10
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.